Researchers studied a TAAR1 variant found in an Indian family with schizophrenia and showed that a single amino acid change ...

It’s a frustration for both doctors who treat patients with schizophrenia and for people living with it: the most effective antipsychotic drugs have side effects, so unpleasant patients would rather ...

In the months after 24-year-old D.J. was diagnosed with schizophrenia, he searched online for answers to questions that felt urgent and existential. Does it get really bad over time? Will I be able to ...

Bristol Myers Squibb believes Alzheimer's is the largest market for its newly approved schizophrenia drug, Cobenfy, which it expects to eventually generate billions of dollars in revenue. In an ...

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

The Food and Drug Administration approved the first new drug in over 30 years to treat schizophrenia in adults. The new drug Cobenfy, formerly known as KarXT, is manufactured by Bristol Myers Squibb, ...

Jan 10 (Reuters) - Abbvie (ABBV.N), opens new tab said on Friday it would record a charge of about $3.5 billion related to its experimental schizophrenia drug, emraclidine, which recently failed in ...

From a pig kidney transplant to restoring genetic deafness, 2024 was a year full of medical breakthroughs. The breakthroughs include the discovery of a cause of an autoimmune disease, the development ...

Rosie is a freelance writer living in London. She has covered everything from ancient Egyptian temples to exciting medical breakthroughs, but she particularly enjoys writing about wildlife, ...

LB Pharmaceuticals (LBRX) climbed ~26% on Thursday as the New York-based biopharma, focused on developing drugs for neurological conditions such as schizophrenia, opened for trading after raising ...